Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gates

Showing results (481-490 of 499) with videos related to

Pageof 50
Sort By:
Molecular Cell|July 16, 2013
Proteomic analysis of coregulators bound to ERα on DNA and nucleosomes reveals coregulator dynamicsCharles E Foulds, Qin Feng, Chen Ding, et al.
Nature Communications|July 1, 2026
Nuclear-specific reductive carboxylation of alpha-ketoglutarate fuels histone acetylation to induce chromatin accessibility and gene activationAbhisha Sawant Dessai, Nadya A Elhalawany, Tao Dai, et al.
Cell Metabolism|April 9, 2020
ZBTB1 Regulates Asparagine Synthesis and Leukemia Cell Response to L-AsparaginaseRobert T Williams, Rohiverth Guarecuco, Leah A Gates, et al.
Plos Neglected Tropical Diseases|March 23, 2022
Development of a dual antigen lateral flow immunoassay for detecting Yersinia pestisDerrick Hau, Brian Wade, Chris Lovejoy, et al.
Developmental Biology|June 19, 1998
The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesisM A Thompson, D G Ransom, S J Pratt, et al.
Protein Science : a Publication of the Protein Society|November 25, 1998
Solution structures of stromelysin complexed to thiadiazole inhibitorsB J Stockman, D J Waldon, J A Gates, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimizationRobert B Perni, Janos Pitlik, Shawn D Britt, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Inhibitors of hepatitis C virus NS3.4A protease 1. Non-charged tetrapeptide variantsRobert B Perni, Shawn D Britt, John C Court, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine proteaseRobert B Perni, Susan J Almquist, Randal A Byrn, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Inhibitors of hepatitis C virus NS3.4A protease. Part 3: P2 proline variantsRobert B Perni, Luc J Farmer, Kevin M Cottrell, et al.
Pageof 50

Showing results (481-490 of 499) with videos related to

Sort By:
Pageof 50
Molecular Cell|July 16, 2013
Proteomic analysis of coregulators bound to ERα on DNA and nucleosomes reveals coregulator dynamicsCharles E Foulds, Qin Feng, Chen Ding, et al.
Nature Communications|July 1, 2026
Nuclear-specific reductive carboxylation of alpha-ketoglutarate fuels histone acetylation to induce chromatin accessibility and gene activationAbhisha Sawant Dessai, Nadya A Elhalawany, Tao Dai, et al.
Cell Metabolism|April 9, 2020
ZBTB1 Regulates Asparagine Synthesis and Leukemia Cell Response to L-AsparaginaseRobert T Williams, Rohiverth Guarecuco, Leah A Gates, et al.
Plos Neglected Tropical Diseases|March 23, 2022
Development of a dual antigen lateral flow immunoassay for detecting Yersinia pestisDerrick Hau, Brian Wade, Chris Lovejoy, et al.
Developmental Biology|June 19, 1998
The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesisM A Thompson, D G Ransom, S J Pratt, et al.
Protein Science : a Publication of the Protein Society|November 25, 1998
Solution structures of stromelysin complexed to thiadiazole inhibitorsB J Stockman, D J Waldon, J A Gates, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimizationRobert B Perni, Janos Pitlik, Shawn D Britt, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Inhibitors of hepatitis C virus NS3.4A protease 1. Non-charged tetrapeptide variantsRobert B Perni, Shawn D Britt, John C Court, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine proteaseRobert B Perni, Susan J Almquist, Randal A Byrn, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Inhibitors of hepatitis C virus NS3.4A protease. Part 3: P2 proline variantsRobert B Perni, Luc J Farmer, Kevin M Cottrell, et al.
Pageof 50